140 related articles for article (PubMed ID: 1301665)
1. [The evaluation of the vibriocidal antibody test in establishing a diagnosis of cholera or Vibrio carriage].
Savel'ev VN; Efremenko VI; Gnutov IN; Kiseleva TF; Bogdanov IK; Postovoĭ PP; Latypova MS; Abolina TA; Degtiareva SN; Onatskiĭ II
Zh Mikrobiol Epidemiol Immunobiol; 1992; (11-12):55-7. PubMed ID: 1301665
[TBL] [Abstract][Full Text] [Related]
2. [Utilization of serological methods in the retrospective diagnosis of cholera and in detecting vibrion carriers].
Bunin KV; Firsanov VI; Kravtsov EG; Nechaeva IP; Efimov DD
Zh Mikrobiol Epidemiol Immunobiol; 1975 Oct; (10):98-101. PubMed ID: 1210898
[TBL] [Abstract][Full Text] [Related]
3. Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique.
Benenson AS; Saad A; Mosley WH
Bull World Health Organ; 1968; 38(2):277-85. PubMed ID: 5302303
[TBL] [Abstract][Full Text] [Related]
4. [The use of immunoenzyme analysis and the vibriocidal antibody reaction in the serological examination of persons who have had cholera and of those in contact with them].
Mareev VI; Moskvitina EA; Gritsenko AN; Ivanova LV; Efanova EA; Nepomniashchaia NB; Dranov IIu; Boldyr' LA; Griseva LN
Zh Mikrobiol Epidemiol Immunobiol; 1991 Feb; (2):34-6. PubMed ID: 1867031
[TBL] [Abstract][Full Text] [Related]
5. [Value of vibriocidal antibody research in endemic areas of Vibrio cholerae 0:1].
Bendib A; Bougoudogo F; Messast M; Rezkallah D; Hamchi L; Bellouche Y; Aidoud NS; Keddouri A; Fournier JM; Dodin A
Bull Soc Pathol Exot; 1994; 87(1):33-7. PubMed ID: 8003902
[TBL] [Abstract][Full Text] [Related]
6. Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae.
Clements ML; Levine MM; Young CR; Black RE; Lim YL; Robins-Browne RM; Craig JP
J Infect Dis; 1982 Apr; 145(4):465-73. PubMed ID: 7069227
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
[TBL] [Abstract][Full Text] [Related]
8. Rapid detection of Vibrio cholerae O1 in stools of Peruvian cholera patients by using monoclonal immunodiagnostic kits. Loyaza Cholera Working Group in Peru.
Carillo L; Gilman RH; Mantle RE; Nunez N; Watanabe J; Moron J; Quispe V; Ramirez-Ramos A
J Clin Microbiol; 1994 Mar; 32(3):856-7. PubMed ID: 8195409
[TBL] [Abstract][Full Text] [Related]
9. [The properties of the Vibrio cholerae strains isolated in large districts in western Dagestan in 1994].
Cherepakhina IIa; Lomov IuM; Karagozova AV; Pomukhina OI; Smolikova LM; Makedonova LD; Dimitrova NI; Nekliaev VN; Balakhnova VV; Chirkova OO
Zh Mikrobiol Epidemiol Immunobiol; 1995; Suppl 2():84-6. PubMed ID: 7771155
[TBL] [Abstract][Full Text] [Related]
10. Vibrio cholerae O1 vibriocidal and anti-cholera toxin antibodies in O139 Bengal cholera patients.
Takeda T; Ramamurthy T; Chowdhury AS; Dutta D; Bhattacharya SK; Deb BC; Nair GB; Takeda Y
J Infect; 1994 Sep; 29(2):233-5. PubMed ID: 7806891
[No Abstract] [Full Text] [Related]
11. IgM specific to lipopolysaccharide of Vibrio cholerae is a surrogate antibody isotype responsible for serum vibriocidal activity.
Yang JS; An SJ; Jang MS; Song M; Han SH
PLoS One; 2019; 14(3):e0213507. PubMed ID: 30845262
[TBL] [Abstract][Full Text] [Related]
12. Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh.
Saha D; LaRocque RC; Khan AI; Harris JB; Begum YA; Akramuzzaman SM; Faruque AS; Ryan ET; Qadri F; Calderwood SB
J Infect Dis; 2004 Jun; 189(12):2318-22. PubMed ID: 15181581
[TBL] [Abstract][Full Text] [Related]
13. Identification and treatment with a long-acting sulphonamide of 15 carriers of Vibrio cholerae El Tor serotype Ogawa, during the 1973 cholera epidemic in Naples.
De Lorenzo F; Buogo A; Soscia M; Schisa C
Chemotherapy; 1977; 23(5):345-55. PubMed ID: 332466
[TBL] [Abstract][Full Text] [Related]
14. [Determination of bactericidal antibodies directed against vibrio cholerae in an adult population in Montevideo].
Varela G; Del'Acqua L; Hortal M
Rev Argent Microbiol; 1995; 27(4):185-90. PubMed ID: 8850130
[TBL] [Abstract][Full Text] [Related]
15. [Detection of convalescent Vibrio cholerae carriers using the enterotest].
Grados P; Battilana C
Bol Oficina Sanit Panam; 1994 Apr; 116(4):285-9. PubMed ID: 8037848
[TBL] [Abstract][Full Text] [Related]
16. Vibriocidal titre in cholera cases and contacts: its value in assessing endemicity of or susceptibility to cholera.
Khan MU; Barua DK; Begum T; Shahidullah M
Trop Geogr Med; 1987 Jul; 39(3):271-5. PubMed ID: 3433343
[TBL] [Abstract][Full Text] [Related]
17. Guinea pig complement potently measures vibriocidal activity of human antibodies in response to cholera vaccines.
Kim KW; Jeong S; Ahn KB; Yang JS; Yun CH; Han SH
J Microbiol; 2017 Dec; 55(12):973-978. PubMed ID: 29214494
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of the vibriocidal antibody response to live oral cholera vaccines.
Wasserman SS; Losonsky GA; Noriega F; Tacket CO; Castañeda E; Levine MM
Vaccine; 1994 Aug; 12(11):1000-3. PubMed ID: 7975839
[TBL] [Abstract][Full Text] [Related]
19. [Seroepidemiology of cholera in Mexico].
González-Bonilla C; Valle-Valdez JG; Núñez-León A; Moguel-Pech L; Villanueva-Zamudio A
Rev Latinoam Microbiol; 1994; 36(4):253-6. PubMed ID: 7701134
[TBL] [Abstract][Full Text] [Related]
20. Safety, immunogenicity, and lot stability of the whole cell/recombinant B subunit (WC/rCTB) cholera vaccine in Peruvian adults and children.
Taylor DN; Cárdenas V; Perez J; Puga R; Svennerholm AM
Am J Trop Med Hyg; 1999 Dec; 61(6):869-73. PubMed ID: 10674661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
